CONFERENCE

Date: September 03 - 04, 2012
City: Warsaw, Poland
Event type: Round Table

About Us Market Reports FAQ Login/Register

+44 20 8123 2220
+1 732 587 5005
info@marketpublishers.com

Market Research Reports > Medicine, Pharmaceuticals & Biotechnology > Drugs & Biotechnology

Drugs & Biotechnology Market Research Reports

Page 2 of 395

Clofarabine - Comprehensive patent search May, 2012	US$ 7,200.00
Boceprevir - Comprehensive patent search May, 2012	US$ 7,200.00
Abiraterone - Comprehensive patent search May, 2012	US$ 7,200.00
Varespladib - Comprehensive patent search May, 2012	US$ 6,400.00
Rilpivirine - Comprehensive patent search May, 2012	US$ 6,400.00
Lurasidone - Comprehensive patent search May, 2012	US$ 6,400.00
Dalcetrapib - Comprehensive patent search May, 2012	US$ 6,400.00
Carfilzomib - Comprehensive patent search May, 2012	US$ 6,400.00
MDV-3100 - Comprehensive patent search May, 2012	US$ 5,600.00
Lisdexamfetamine - Comprehensive patent search May, 2012	US$ 5,600.00
Varespladib - Key patent, SPC, and data exclusivity expiry (44 country coverage) May, 2012	US$ 1,200.00
Nintedanib - Key patent, SPC, and data exclusivity expiry (44 country coverage) May, 2012	US$ 1,200.00
MDV-3100 - Key patent, SPC, and data exclusivity expiry (44 country coverage) May, 2012	US$ 1,200.00
Lurasidone - Key patent, SPC, and data exclusivity expiry (44 country coverage) May, 2012	US$ 1,200.00
Dalcetrapib - Key patent, SPC, and data exclusivity expiry (44 country coverage) May, 2012	US$ 1,200.00
Carfilzomib - Key patent, SPC, and data exclusivity expiry (44 country coverage) May, 2012	US$ 1,200.00
Varespladib - Key patent, SPC, and data exclusivity expiry (7 country coverage) May, 2012	US$ 500.00
Nintedanib - Key patent, SPC, and data exclusivity expiry (7 country coverage) May, 2012	US$ 500.00
MDV-3100 - Key patent, SPC, and data exclusivity expiry (7 country coverage) May, 2012	US$ 500.00
Lurasidone - Key patent, SPC, and data exclusivity expiry (7 country coverage) May, 2012	US$ 500.00

1 2 3 4 5 6 7 8 9 10 11 ... 395

Home FAQ Terms & Conditions Contact Us